The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs
Open accessAbstract
The rapid emergence of multidrug-resistant pathogens has evolved into a global health problem as current treatment options are failing for infections caused by pan-resistant bacteria. Hence, novel antibiotics are in high demand, and for this reason antimicrobial peptides (AMPs) have attracted considerable interest, since they often show broad-spectrum activity, fast killing and high cell selectivity. However, the therapeutic potential of natural AMPs is limited by their short plasma half-life. Antimicrobial peptidomimetics mimic the structure and biological activity of AMPs, but display extended stability in the presence of biological matrices. In the present review, focus is on the developments reported in the last decade with respect to their design, synthesis, antimicrobial activity, cytotoxic side effects as well as their potential applications as anti-infective agents. Specifically, only peptidomimetics with a modular structure of residues connected via amide linkages will be discussed. These comprise the classes of α-peptoids (N-alkylated glycine oligomers), β-peptoids (N-alkylated β-alanine oligomers), β3-peptides, α/β3-peptides, α-peptide/β-peptoid hybrids, α/γ N-acylated N-aminoethylpeptides (AApeptides), and oligoacyllysines (OAKs). Such peptidomimetics are of particular interest due to their potent antimicrobial activity, versatile design, and convenient optimization via assembly by standard solid-phase procedures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–207 of 207
Oddo, A., Münzker, L., & Hansen, P. B. (2015) · Organic Letters · doi:10.1021/acs.orglett.5b01026 · Cited by 16
Self-citationN-Substituted arylsulfonamide building blocks as alternative submonomers for peptoid synthesis
Vézina‐Dawod, S., Derson, A., & Biron, É. (2014) · Tetrahedron Letters · doi:10.1016/j.tetlet.2014.11.104 · Cited by 15
Antibacterial Properties of an Oligo-Acyl-Lysyl Hexamer Targeting Gram-Negative Species
Zaknoon, F., Goldberg, K., Sarig, H., Epand, R. F., Epand, R. M., & Mor, A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00511-12 · Cited by 15
1,4-Dihydropyridine Cationic Peptidomimetics with Antibacterial Activity
Lapidot, I., Albeck, A., Gellerman, G., Shatzmiller, S. E., & Grynszpan, F. (2015) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-015-9460-1 · Cited by 13
Design, Synthesis and Characterization of fMLF‐Mimicking AApeptides
Hu, Y., Cheng, N., Wu, H., Kang, S., Ye, R. D., & Cai, J. (2014) · ChemBioChem · doi:10.1002/cbic.201402396 · Cited by 10
Jeong, M., Jeon, D., Shin, A., Jin, S., Shin, S. Y., Park, Y. S., & Kim, Y. (2016) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.10959 · Cited by 10
Antiplasmodial Properties of Acyl-Lysyl Oligomers in Culture and Animal Models of Malaria
Zaknoon, F., Wein, S., Krugliak, M., Meir, O., Rotem, S., Ginsburg, H., Vial, H. J., & Mor, A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00129-11 · Cited by 9
Cited by
The global preclinical antibacterial pipeline
Theuretzbacher, U., Outterson, K., Engel, A., & Karlén, A. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0288-0 · Cited by 738
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics
Murugaiyan, J., Kumar, P. A., Rao, G. S., Iskandar, K., Hawser, S., Hays, J. P., Mohsen, Y., Adukkadukkam, S., Awuah, W. A., Jose, R. A. M., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11020200 · Cited by 567
Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era
Wang, J., Dou, X., Song, J., Lyu, Y., Zhu, X., Xu, L., Li, W., & Shan, A. (2019) · Medicinal Research Reviews · doi:10.1002/med.21542 · Cited by 547
Gan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 511
Antimicrobial peptides as therapeutic agents: opportunities and challenges
Mahlapuu, M., Björn, C., & Ekblom, J. (2020) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2020.1796576 · Cited by 484
Metadata
- Authors
- Molchanova, N., Hansen, P., & Franzyk, H.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2017-08-29
- Volume
- 22
- Issue
- 9
- Pages
- 1430
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2752567037
- Cited by
- 257
- References
- 207
- FWCI
- 18.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.